Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Gross Profit (2020 - 2025)

Historic Gross Profit for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $1.3 million.

  • Roivant Sciences' Gross Profit fell 8516.95% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.5 million, marking a year-over-year decrease of 6255.33%. This contributed to the annual value of $28.1 million for FY2025, which is 955.2% down from last year.
  • Latest data reveals that Roivant Sciences reported Gross Profit of $1.3 million as of Q4 2025, which was down 8516.95% from $1.5 million recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Gross Profit registered a high of $23.0 million during Q4 2021, and its lowest value of $1.3 million during Q4 2025.
  • In the last 5 years, Roivant Sciences' Gross Profit had a median value of $7.6 million in 2021 and averaged $8.3 million.
  • In the last 5 years, Roivant Sciences' Gross Profit surged by 115098.68% in 2021 and then crashed by 8516.95% in 2025.
  • Roivant Sciences' Gross Profit (Quarter) stood at $23.0 million in 2021, then crashed by 41.34% to $13.5 million in 2022, then rose by 14.1% to $15.4 million in 2023, then crashed by 42.99% to $8.8 million in 2024, then tumbled by 85.17% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q4 2025, $1.5 million for Q3 2025, and $2.0 million during Q2 2025.